Cargando…
Erratum to: Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism
Autores principales: | Chen, Yunliang, Leask, Andrew, Abraham, David J, Kennedy, Laura, Shi-wen, Xu, Denton, Christopher P, Black, Carol M, Verjee, Liaquat S, Eastwood, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359549/ https://www.ncbi.nlm.nih.gov/pubmed/25774218 http://dx.doi.org/10.1186/s13069-015-0021-1 |
Ejemplares similares
-
Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism
por: Chen, Yunliang, et al.
Publicado: (2011) -
Regulation of the Mitogen Activated Protein Kinase Kinase (MEK)-1 by NAD(+)-Dependent Deacetylases
por: Yeung, Fan, et al.
Publicado: (2014) -
Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells
por: YAMAMOTO, Miu, et al.
Publicado: (2023) -
Nuclear Export of Map Kinase (ERK) Involves a Map Kinase Kinase (Mek-Dependent) Active Transport Mechanism
por: Adachi, Makoto, et al.
Publicado: (2000) -
Erratum to: ‘Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice’
por: Napp, L. Christian, et al.
Publicado: (2016)